Fred Hutchinson Cancer Center Clinical Trials
Sponsors / Fred Hutchinson Cancer Center
The ClinicalTrials.gov registry records 490 trials led by Fred Hutchinson Cancer Center. 47 trials are actively recruiting participants, 19 remain active without open enrollment, and 337 have concluded. 61 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. The cumulative planned enrollment figure across all listed trials is 233,704 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.
490
Total Trials
47
Recruiting
19
Other Active
337
Completed
61
Terminated / Withdrawn
233,704
Total Enrollment
Termination reasons: Recruitment36% · Funding30% · Other18% · Efficacy8% · Safety5% · Regulatory3%
Recent Terminations
- Acute Respiratory Failure"due to increased mortality and futility analyses"
- Metastatic Pancreatic Ductal Adenocarcinoma"Study terminated due to end of funding."
- Human Papillomavirus-Related Carcinoma"This study has been terminated due to the conclusion of funding. We were able to collect data on primary outcomes through pharmacy staff, but due to recruitment challenges were not able to complete secondary outcome recruitment."
- Lung Carcinoma"Terminated due to end of funding. Enrollment sufficient to evaluate primary and secondary outcomes measures."
- Acute Myeloid Leukemia"Terminated due to low accrual"
- Chronic Graft Versus Host Disease"Study closed to accrual early due to side effects of study drug."
- COVID-19 Infection"Terminated due to FDA withdrawal of the emergency use authorization (EUA) for sotrovimab"
- Acute Erythroid Leukemia"The federal funding period ended. The study was originally intended to be multi-site but was only conducted at the lead site. Due to the rarity of the subject population \& smaller # of enrolling sites, we were not able to reach accrual goa"
- Colorectal Carcinoma"Terminated due to low accrual"
- Anatomic Stage IV Breast Cancer AJCC v8"Terminated due to slow accrual."
Active Trials (19 total)
- NCT06934369
- NCT07194980
- NCT07225985
- NCT07141407
- NCT07459621
- NCT07535008
- NCT07052630
- NCT05952804
- NCT05075759
- NCT04384692
- Acute Leukemia PHASE2NCT03970096
- NCT03980769
- NCT04829136
- Aplastic Anemia PHASE2NCT06752694
- NCT05067595
- Recurrent Multiple Myeloma PHASE1/PHASE2NCT07181941
- NCT04375631
- Autoimmune Disease PHASE2NCT06817889
- Autoimmune Disease PHASE2NCT00716066
- Acute Leukemia PHASE2NCT04195633
Top Conditions
Leukemia (34) Breast cancer (15) Accelerated phase chronic myelogenous leukemia (14) Adult acute myeloid leukemia with 11q23 (mll) abnormalities (10) Cancer (10) Acute biphenotypic leukemia (9) Acute myeloid leukemia (9) Chronic myeloproliferative disorders (8) Cigarette smoking-related carcinoma (8) Graft versus host disease (8)